Search Results - "Patel, Sushma"

Characteristics of initiators of budesonide/glycopyrrolate/formoterol for treatment of chronic obstructive pulmonary disease (COPD) in the United States: the AURA study by Portillo, Edward C., Pollack, Michael, Lee, Inyoung, Sun, Kainan, Zhao, Xiaohui, Kruse, Lisa, Feigler, Norbert, Patel, Sushma, Near, Aimee M.

“…Introduction: A twice-daily single inhaler triple therapy consisting of budesonide/glycopyrrolate/formoterol fumarate (BGF) was approved by the US Food and…”
Get full text

Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering by Sparrow, Carl P, Burton, Charlotte A, Hernandez, Melba, Mundt, Steven, Hassing, Heide, Patel, Sushma, Rosa, Ray, Hermanowski-Vosatka, Anne, Wang, Pei-Ran, Zhang, Donghui, Peterson, Larry, Detmers, Patricia A, Chao, Yu-Sheng, Wright, Samuel D

“…Abstract—Inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase, such as simvastatin, lower circulating cholesterol levels and prevent myocardial…”
Get full text

Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3 by Geissler, Wayne M, Davis, Daphne L, Wu, Ling, Bradshaw, Karen D, Patel, Sushma, Mendonca, Berenice B, Elliston, Keith O, Wilson, Jean D, Russell, David W, Andersson, Stefan

“…Defects in the conversion of androstenedione to testosterone in the fetal testes by the enzyme 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) give rise to…”
Get full text

A fluorescent cholesterol analog traces cholesterol absorption in hamsters and is esterified in vivo and in vitro by Sparrow, C P, Patel, S, Baffic, J, Chao, Y S, Hernandez, M, Lam, M H, Montenegro, J, Wright, S D, Detmers, P A

“…The fluorescent cholesterol analog 22-(N-(7-nitrobenz-2-oxa-1, 3-diazol-4-yl)amino)-23,24-bisnor-5-cholen-3beta-ol (fluoresterol) was characterized as a tool…”
Get full text

Lipid-based emulsion drug delivery systems — a comprehensive review by Dhaval, Mori, Vaghela, Poonam, Patel, Kajal, Sojitra, Keshvi, Patel, Mohini, Patel, Sushma, Dudhat, Kiran, Shah, Sunny, Manek, Ravi, Parmar, Ramesh

“…Lipid-based emulsion system — a subcategory of emulsion technology, has emerged as an enticing option to improve the solubility of the steadily rising…”
Get full text

HEALTH CARE RESOURCE USE AND COSTS ASSOCIATED WITH PROMPT INITIATION OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE AMONG PATIENTS WITH COPD: THE EROS STUDY by POLLACK, MICHAEL, TKACZ, JOSEPH, SCHINKEL, JILL, LEWING, BENJAMIN, AGATEP, BARNABIE, SWISHER, SEAN, PATEL, SUSHMA, EDWARDS, DEVECHIO, TOUCHETTE, DANIEL, PORTILLO, EDWARD C, FEIGLER, NORBERT, STRANGE, CHARLIE

Get full text

PROMPT INITIATION OF MAINTENANCE THERAPY IN THE UNITED STATES (PRIMUS): AN ANALYSIS OF TRIPLE THERAPY FOLLOWING A DISEASE EXACERBATION AMONG PATIENTS WITH COPD by TKACZ, JOSEPH, EVANS, KRISTIN, TOUCHETTE, DANIEL, PORTILLO, ED, STRANGE, CHARLIE, STARESINIC, ANTHONY, FEIGLER, NORBERT, PATEL, SUSHMA, POLLACK, MICHAEL

Get full text

CHARACTERISTICS OF EARLY ADOPTERS OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL: A SINGLE-INHALER TRIPLE THERAPY FOR COPD by POLLACK, MICHAEL, G NOORDUYN, STEPHEN, LEE, INYOUNG, KS SUN, KAINAN, ZHAO, XIAOHUI, K KRUSE, LISA, FEIGLER, NORBERT, M. PATEL, SUSHMA, NEAR, AIMEE

Get full text

PROMPTLY INITIATING TRIPLE THERAPY FOLLOWING SECOND MODERATE EXACERBATION AMONG PATIENTS WITH COPD IN THE UNITED STATES: ANALYSIS OF THE PRIMUS STUDY by EVANS, KRISTIN A, POLLACK, MICHAEL, TKACZ, JOSEPH, R TOUCHETTE, DANIEL, C PORTILLO, EDWARD, STRANGE, CHARLIE, STARESINIC, ANTHONY, M. PATEL, SUSHMA, FEIGLER, NORBERT

Get full text

Understanding Treatment of Severe Anemia due to CKD: A Descriptive Study in Non-Dialysis Medicare Advantage Prescription Drug Plan Patients: PO0273 by Davis, Jill, Suehs, Brandon, Xu, Yihua, Patel, Sushma, Schilling, Craig G., Bunniran, Suvapun, Perkins, Robert M., Vuong, Kelly

Get full text

Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study by Evans, Kristin A, Pollack, Michael, Portillo, Edward, Strange, Charlie, Touchette, Daniel R, Staresinic, Anthony, Patel, Sushma, Tkacz, Joseph, Feigler, Norbert

“…Severe exacerbations requiring hospitalization contribute a substantial portion of the morbidity and costs of chronic obstructive pulmonary disease (COPD)…”
Get full text

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/ Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS by Lewing, Benjamin, Portillo, Edward, Swisher, Sean, Tkacz, Joseph, Touchette, Daniel R, Edwards, Devechio, Pollack, Michael, Agatep, Barnabie, Schinkel, Jill, Patel, Sushma, Strange, Charlie, Feigler, Norbert

“…Purpose: Triple therapy to prevent exacerbations from chronic obstructive pulmonary disease (COPD) is associated with improved health compared to single and…”
Get full text

Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial by Sperl, Jan, Horvath, Gabor, Halota, Waldemar, Ruiz-Tapiador, Juan Arenas, Streinu-Cercel, Anca, Jancoriene, Ligita, Werling, Klara, Kileng, Hege, Koklu, Seyfettin, Gerstoft, Jan, Urbanek, Petr, Flisiak, Robert, Leiva, Rafael, Kazenaite, Edita, Prinzing, Renate, Patel, Sushma, Qiu, Jingjun, Asante-Appiah, Ernest, Wahl, Janice, Nguyen, Bach-Yen, Barr, Eliav, Platt, Heather L

“…Graphical abstract…”
Get full text

PRIMUS - Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation by Tkacz, Joseph, Evans, Kristin A, Touchette, Daniel R, Portillo, Edward, Strange, Charlie, Staresinic, Anthony, Feigler, Norbert, Patel, Sushma, Pollack, Michael

“…Patients with chronic obstructive pulmonary disease (COPD) may experience moderate (requiring outpatient care) or severe (requiring hospitalization) disease…”
Get full text

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study [Corrigendum] by Strange, Charlie, Tkacz, Joseph, Schinkel, Jill, Lewing, Benjamin, Agatep, Barnabie, Swisher, Sean, Patel, Sushma, Edwards, Devechio, Touchette, Daniel, Portillo, Edward, Feigler, Norbert, Pollack, Michael

“…Strange C, Tkacz J, Schinkel J, et al. Int J Chron Obstruct Pulmon Dis. 2023;18:2245-2256. The authors have advised that there are errors in the 95% CI…”
Get full text

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study by Strange, Charlie, Tkacz, Joseph, Schinkel, Jill, Lewing, Benjamin, Agatep, Barnabie, Swisher, Sean, Patel, Sushma, Edwards, Devechio, Touchette, Daniel R, Portillo, Edward, Feigler, Norbert, Pollack, Michael

“…Triple therapy to prevent exacerbations from chronic obstructive pulmonary disease (COPD) is associated with improved health compared to single and dual-agent…”
Get full text

Isolation of plasma membrane complexes from Xenopus oocytes by WALL, D. A, SUSHMA PATEL

“…A method for the isolation of plasma membrane fractions from Xenopus oocytes has been developed, and the membranes have been characterized biochemically and…”
Get full text

Evaluation of the role of UGT1A1 genotype testing in colorectal cancer patients administered irinotecan and the occurence of grade 3 and 4 neutropenia by Patel, Sushma M., Chan, Jim, Hui, Rita L., Spence, Michele M.

“…Abstract only 412 Background: Irinotecan is metabolized primarily in the liver by the carboxylesterase enzyme to the SN-38 active metabolite and is then…”
Get full text

Description of the outcomes of prior authorization of palivizumab for prevention of respiratory syncytial virus infection in a managed care organization by Buckley, Brieana C, Roylance, Derek, Mitchell, Matthew P, Patel, Sushma M, Cannon, H Eric, Dunn, Jeffrey D

“…Respiratory syncytial virus (RSV) is the leading cause of upper and lower respiratory tract infections in infants and young children. Most children are exposed…”
Get full text

Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir by Ng, Xinyi, Nwankwo, Chizoba, Arduino, Jean Marie, Corman, Shelby, Lasch, Kathryn Eilene, Lustrino, Jacqueline Mary, Patel, Sushma, Platt, Heather Loryn, Qiu, Jingjun, Sperl, Jan

“…People chronically infected with hepatitis C virus (HCV) have diminished patient-reported outcomes (PROs). This study aimed to compare the impact of…”
Get full text